These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2851184)

  • 1. The present status of rotavirus vaccine development.
    Bishop R
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):429-35. PubMed ID: 2851184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and immunological studies of rotavirus vaccines.
    Vesikari T
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):437-47. PubMed ID: 2851185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rotavirus infections and their prevention with vaccines in children].
    Chippaux-Hyppolite C; Loukou Yao G; Chippaux A
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):918-25. PubMed ID: 1668070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.
    Kapikian AZ; Flores J; Hoshino Y; Midthun K; Gorziglia M; Green KY; Chanock RM; Potash L; Sears SD; Clements ML
    Rev Infect Dis; 1989; 11 Suppl 3():S539-46. PubMed ID: 2548276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.
    Vesikari T; Clark HF; Offit PA; Dallas MJ; DiStefano DJ; Goveia MG; Ward RL; Schödel F; Karvonen A; Drummond JE; DiNubile MJ; Heaton PM
    Vaccine; 2006 May; 24(22):4821-9. PubMed ID: 16621194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rotaviruses in human and veterinary medicine].
    Dodet B; Heseltine E; Mary C; Saliou P
    Sante; 1997; 7(3):195-9. PubMed ID: 9296811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.
    Vesikari T; Karvonen AV; Majuri J; Zeng SQ; Pang XL; Kohberger R; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
    J Infect Dis; 2006 Aug; 194(3):370-6. PubMed ID: 16826486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus vaccines--an update.
    Dennehy PH
    Vaccine; 2007 Apr; 25(16):3137-41. PubMed ID: 17321017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of a rotavirus vaccine. Field trials in Venezuela].
    Pérez Schael I; Rojas Mazzei AM; Flores J
    Acta Cient Venez; 1991; 42(6):296-312. PubMed ID: 1668865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current status of diarrhoea related vaccines.
    Sarkar SK; Pal SC
    Indian J Public Health; 1990; 34(1):20-34. PubMed ID: 1966245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotavirus vaccines: entering a new stage of deployment.
    Nakagomi O; Cunliffe NA
    Curr Opin Infect Dis; 2007 Oct; 20(5):501-7. PubMed ID: 17762784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of candidate rotavirus vaccines derived from neonatal strains in India.
    Glass RI; Bhan MK; Ray P; Bahl R; Parashar UD; Greenberg H; Rao CD; Bhandari N; Maldonado Y; Ward RL; Bernstein DI; Gentsch JR
    J Infect Dis; 2005 Sep; 192 Suppl 1():S30-5. PubMed ID: 16088802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
    Vesikari T; Rautanen T; Varis T; Beards GM; Kapikian AZ
    Am J Dis Child; 1990 Mar; 144(3):285-9. PubMed ID: 2154925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.
    Clark HF; Offit PA; Plotkin SA; Heaton PM
    Pediatr Infect Dis J; 2006 Jul; 25(7):577-83. PubMed ID: 16804425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.
    Phua KB; Quak SH; Lee BW; Emmanuel SC; Goh P; Han HH; De Vos B; Bock HL
    J Infect Dis; 2005 Sep; 192 Suppl 1():S6-S16. PubMed ID: 16088807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
    Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B
    Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants.
    Zoppi G; Ferrarini G; Rigolin F; Bogaerts H; André FE
    Helv Paediatr Acta; 1986 Aug; 41(3):203-8. PubMed ID: 3019954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotavirus serotypes: classification and importance in epidemiology, immunity, and vaccine development.
    Hoshino Y; Kapikian AZ
    J Health Popul Nutr; 2000 Jun; 18(1):5-14. PubMed ID: 11014764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.